FLL-67423-23199
4 vaccinations
6 coded responses
32 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 900 / CA
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Registered in v-safe
- 2021-03-16
- 2021-03-21
-
2021-03-28
Dose 2 — Pfizer-BioNTech
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Breast tenderness — Feeling: Good · HeadacheFree text: Ive forgotten to note this on the previous forms, but Ive had acute tenderness in my left breast (the side where I got the shot) consistently since receiving it. It started as severe for the first two days, then felt moderate for the following two days, and has felt mild since.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
-
2021-04-04
Survey response — day 7, dose 2MedDRA: Breast tenderness — Feeling: GoodFree text: Tenderness (mild) in left breastMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-19
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-06-27
- 2021-09-26
-
2021-12-02
Dose 3 — Moderna
-
2022-03-28
Survey response — 12 months, dose 2MedDRA: Adnexa uteri pain, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Sustained pain in one of my ovaries · Healthcare visit (other): I went to the doctors office and had an ultrasound performedMedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-29
-
2022-04-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-09-18
Dose 4 — Pfizer-BioNTech
-
2022-09-19
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain, Pelvic pain — Feeling: Good · Site: PainFree text: Sore at the site of injection, some pelvic soreness as wellMedDRA releases: 2024-11 · check-in free text available
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-25
- 2022-10-30
-
2022-12-18
Survey response — 3 months, dose 4MedDRA: Cough, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: PoorFree text: congested and coughing. PCR and antigen tests have confirmed I do not have COVIDMedDRA releases: 2024-11 · check-in free text available
-
2023-03-19
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-28 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Moderna | No |
| 4 | 2022-09-18 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Ive forgotten to note this on the previous forms, but Ive had acute tenderness in my left breast (the side where I got the shot) consistently since receiving it. It started as severe for the first two days, then felt moderate for the following two days, and has felt mild since.
Release 6 — day 7, dose 2
Systemic reaction (other): Tenderness (mild) in left breast
Release 11 — 12 months, dose 2
Symptoms: Sustained pain in one of my ovaries
Healthcare visit (other): I went to the doctors office and had an ultrasound performed
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sore at the site of injection, some pelvic soreness as well
Release 12 — 3 months, dose 4
Symptoms: congested and coughing. PCR and antigen tests have confirmed I do not have COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adnexa uteri pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Breast tenderness | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Pelvic pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release